Xiphoid process-derived chondrocytes: a novel cell source for elastic cartilage regeneration

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Cell Biology

Background:

• Elastic cartilage reconstruction is hindered by the limited availability of suitable chondrocyte sources.
• Existing elastic cartilage tissues are often indispensable for form and function, making donation problematic.
• Vestigial cartilage in xiphoid processes presents a potential, untapped source.

Purpose of the Study:

• To identify and characterize a novel source of chondrocytes for elastic cartilage regeneration.
• To evaluate the in vitro expansion and differentiation potential of xiphoid process-derived chondrocytes (XCs).
• To assess the in vivo tissue-specific regeneration capacity of XCs.

Main Methods:

• Characterization of cartilage from xiphoid processes (hyaline and elastic regions).
• In vitro assessment of XCs' expansion ability using colony-forming unit fibroblast assays, cell yield, and cumulative growth.
• Induction of mesenchymal lineage differentiation and evaluation of chondrogenic potential.
• Subcutaneous transplantation and autologous chondrocyte implantation models to assess in vivo regeneration.

Main Results:

• Xiphoid process cartilage comprises both hyaline and elastic regions.
• XCs exhibited superior in vitro expansion and proliferation capabilities.
• XCs demonstrated a strong propensity for chondrogenic differentiation upon induction.
• Reliable regeneration of elastic cartilage was confirmed in vivo, irrespective of implantation site.

Conclusions:

• Xiphoid process cartilage is a unique and accessible source of elastic chondrocytes.
• XCs possess excellent in vitro expansion and reliable differentiation potential for chondrogenesis.
• XCs represent a promising cell source for the reconstruction of elastic cartilage defects.